DOCETAXEL ACCORD 20 mg/ml Vial 8 ml: Advanced Chemotherapy Solution

DOCETAXEL ACCORD 20 mg/ml Vial 8 ml is a potent antineoplastic agent designed for the treatment of various cancers.

This medication, from Accord Healthcare, is a crucial component in chemotherapy regimens.

It is carefully formulated to deliver targeted action against cancer cells, supporting patients in their fight against the disease.

You can find more information and related products on platforms like Nahdi Online, , and .

Benefits of Use:

DOCETAXEL ACCORD is primarily used in the treatment of several types of cancer, offering significant therapeutic benefits:

• Effective in treating breast cancer.
• Used for non-small cell lung cancer.
• Applied in the management of prostate cancer.
• Indicated for gastric adenocarcinoma.
• Also used for head and neck cancer.

How to Use:

1. DOCETAXEL ACCORD is for intravenous administration only.
2. It should be administered by a healthcare professional experienced in chemotherapy.
3. The usual dose and treatment schedule are determined by your physician based on your specific cancer type, body surface area, and overall health.
4. Premedication with corticosteroids, such as dexamethasone, is typically required prior to each docetaxel infusion to reduce the incidence and severity of hypersensitivity reactions and fluid retention.
5. The solution should be diluted prior to infusion in either 0.9% sodium chloride solution or 5% glucose solution.
6. Infusion is usually administered over one hour.
7. Strict adherence to the prescribed dosage and administration instructions is essential for optimal treatment outcomes.

Caution & Warnings:

• Must be administered under the supervision of a qualified physician experienced in the use of anticancer chemotherapy.
• Close monitoring for hypersensitivity reactions is required, especially during the first and subsequent infusions.
• Patients should be monitored for myelosuppression (decrease in blood cell counts), which may lead to increased risk of infection and bleeding.
• Fluid retention, which can manifest as peripheral edema, pleural effusion, or ascites, should be carefully managed.
• Neurotoxicity, including peripheral neuropathy, may occur and requires careful assessment.
• Docetaxel is contraindicated in patients with severe liver impairment.
• Not recommended for use during pregnancy and breastfeeding due to potential harm to the fetus or infant.
• Avoid contact with skin and mucous membranes during preparation and administration.
• Keep out of reach of children.

Ingredients:

Active Ingredient:

• Docetaxel 20 mg/ml

Excipients include:

• Polysorbate 80
• Ethanol
• Water for Injections

Product Details:

• Strength: Each ml contains 20 mg of Docetaxel.
• Volume: Each vial contains 8 ml of solution, providing a total of 160 mg of Docetaxel per vial.
• Form: Concentrate for solution for infusion.
• Manufacturer: Accord Healthcare.
• Storage: Store unopened vials in a refrigerator at 2°C to 8°C (36°F to 46°F). Protect from light.
• Packaging: Clear glass vial with a stopper and flip-off cap.